MEDCAMP S.A. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.558 PLN | -3.79% |
|
-7.00% | -4.45% |
| 02-12 | Medcamp S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
| 02-12 | Medcamp S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Sales 2021 | 10K 2.48K 3.39K | Sales 2022 | - | Capitalization | 24.84M 6.16M 8.43M |
|---|---|---|---|---|---|
| Net income 2021 | -2M -496K -679K | Net income 2022 | -5M -1.24M -1.7M | EV / Sales 2021 | 3,860 x |
| Net cash position 2021 | 13.7M 3.4M 4.65M | Net cash position 2022 | 8.17M 2.03M 2.77M | EV / Sales 2022 | - |
| P/E ratio 2021 |
-24.4
x | P/E ratio 2022 |
-4.49
x | Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 30.08% |
More Fundamentals
* Assessed data
More news
| 1 day | -3.79% | ||
| 1 week | -7.00% | ||
| Current month | -10.00% | ||
| 1 month | -2.11% | ||
| 3 months | -6.69% | ||
| 6 months | -11.43% | ||
| Current year | -4.45% |
1 week
0.55
0.61
1 month
0.550.62
Current year
0.550.77
1 year
0.541.22
3 years
0.543.85
5 years
0.2019.30
10 years
0.1619.30
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 61 | 15-12-21 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Mariusz Koitka
CHM | Chairman | 59 | 15-10-26 |
Bogdan Kasprzyk
BRD | Director/Board Member | - | - |
Lukasz Gorski
BRD | Director/Board Member | 45 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 0.558 | -3.79% | 4,377 |
| 24-04-25 | 0.58 | -3.33% | 2,530 |
| 24-04-23 | 0.6 | 0.00% | 24 |
End-of-day quote Warsaw S.E., April 25, 2024
More quotes
Medcamp SA, formerly T2 Investment SA, is a Poland-based company engaged in the real estate operations. The Company is involved in the acquisition, management, redevelopment and upgrade, as well as rental and sale of commercial properties, including office areas and warehouses. In addition, the Company is involved in long-term investments in construction and real estate entities. It conducts rental and redevelopment projects, such as Poznan, Jasielska; Poznan, Komorniki; Poznan, Jasielska, Inkubator; Szamotuly, Dworcowa; among others. The Company aims to build a research and development center in Poznan, specializing in such areas as personalized medicine, genetics, genomics and bioinformatics, supported by artificial intelligence, The Company operates through subsidiaries, including T2 Inkubator Sp z o o, T2 Szamotuly Sp z o o, Polskie Centrum Badan i Rozwoju Sp z o o, among others. The majority shareholder of the Company is Moonrock Enterprise SA.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.45% | 3.6M | |
| +36.16% | 27.94B | |
| -13.74% | 26.97B | |
| +25.00% | 26.95B | |
| -0.71% | 25.32B | |
| +44.49% | 22.58B | |
| +2.78% | 19.59B | |
| +1.45% | 19.52B | |
| +28.54% | 16.23B | |
| -14.80% | 14.98B |
- Stock Market
- Equities
- MDP Stock
